VALPROATE, HYPERAMMONAEMIA, AND HYPERGLYCINAEMIA
dc.contributor.author | Jaeken, J. | en_US |
dc.contributor.author | Casaer, P. | en_US |
dc.contributor.author | Corbeel, L. | en_US |
dc.contributor.author | Coulter, David L. | en_US |
dc.contributor.author | Sills, J. A. | en_US |
dc.contributor.author | Trefor Jones, R. H. | en_US |
dc.contributor.author | Taylor, W. H. | en_US |
dc.date.accessioned | 2006-04-07T17:22:31Z | |
dc.date.available | 2006-04-07T17:22:31Z | |
dc.date.issued | 1980-08-02 | en_US |
dc.identifier.citation | Jaeken, J., Casaer, P., Corbeel, L., Coulter, DavidL., Sills, J. A., Trefor Jones, R. H., Taylor, W. H. (1980/08/02)."VALPROATE, HYPERAMMONAEMIA, AND HYPERGLYCINAEMIA." The Lancet 316(8188): 260-261. <http://hdl.handle.net/2027.42/23174> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6T1B-49H7GJV-1B7/2/ab4ebf45a0d036c939d052fc9035eede | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/23174 | |
dc.format.extent | 333830 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | VALPROATE, HYPERAMMONAEMIA, AND HYPERGLYCINAEMIA | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Medicine (General) | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Departments of Pediatrics and Neurology, University of Michigan Medical Center, Ann Arbor, Michigan 48109, U.S.A.. | en_US |
dc.contributor.affiliationother | Department of Pædiatrics, University of Leuven, 3000, Leuven, Belgium | en_US |
dc.contributor.affiliationother | Department of Pædiatrics, University of Leuven, 3000, Leuven, Belgium | en_US |
dc.contributor.affiliationother | Department of Pædiatrics, University of Leuven, 3000, Leuven, Belgium | en_US |
dc.contributor.affiliationother | Whiston Hospital, Prescot, Merseyside, United Kingdom | en_US |
dc.contributor.affiliationother | Bridgend General Hospital, Bridgend, Mid-Glamorgan, Ireland | en_US |
dc.contributor.affiliationother | Department of Chemical Pathology, Royal Liverpool Hospital, Liverpool L7 8XW, United Kingdom | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/23174/1/0000099.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/S0140-6736(80)90148-8 | en_US |
dc.identifier.source | The Lancet | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.